While some of these drugs showed low micromolar inhibition of hTS and protein dimer disrupting activity (Costantino et al., 2022), they did not cause a measurable inhibition of cancer cell growth, possibly because of poor cellular uptake and/or fast extrusion. Here, APCDD1 is linked to cancer.